Antihypertensive therapy and survival of patients with atherosclerotic heart disease
Gifford, R.W.
Mayo Clinic Proceedings 58(4): 275-276
1983
ISSN/ISBN: 0025-6196 PMID: 6834897 Document Number: 200402
Document emailed within 1 workday
Related Documents
Pignone, M.; Mulrow, C. 2002: Antiplatelet therapy and atherosclerotic events. Risks and patients' values need to be included in decision about aspirin for prevention of coronary heart disease Bmj 324(7342): 917Liu, T.T.; Li, Y.; Yao, S.Y.; Wang, C.; Wang, M.; Liu, J.; Shi, Y.J.; Xue, H. 2019: Effect of individualized antihypertensive therapy on the blood pressure and left ventricular hypertrophy of hypertensive patients with coronary heart disease Zhonghua Yi Xue Za Zhi 99(13): 977-982
Khoroshaeva, R.A.; Sharapov, N.U. 2002: Differential diagnosis of ischemic heart disease in patients with associated atherosclerotic lesions Klinicheskaia Meditsina 80(11): 59-61
Wang, R.M. 1994: Nursing observation of arrhythmia in patients with coronary atherosclerotic heart disease during nocturnal sleep Zhonghua Hu Li Za Zhi 29(12): 729-731
Levey, R.I.; Leren, P. 1986: Selection of initial antihypertensive therapy: new perspectives on coronary heart disease. Risk factors provide new insights. Introduction American Journal of Medicine 80(2a): 1-2
Serkova, V.K.; Burdeĭnaia, L.V. 2002: Effect of antihypertensive therapy on indices for lipid peroxidation and antioxidant system in patients with hypertensive heart Likars'ka Sprava 2002(5-6): 12-16
Belov, I.V.; Salgalov, A.V.; Gadzhiev, N.A. 1992: Diagnosis and therapeutic approach to ischemic heart disease in patients with atherosclerotic lesions of the abdominal aorta and of the main leg arteries Kardiologiia 32(9-10): 75-78
Roffi, M.; Bonvini, R.F.; Righini, M. 2012: Role of endovascular therapy in the management of patients with lower extremity atherosclerotic disease according to new European guidelines Revue Medicale Suisse 8(343): 1164-6 1168-9
Goicoechea, M.A. 2004: Antihypertensive therapy in patients with 4 and 5 stage chronic kidney disease undergoing periodic dialysis Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 24 Suppl (6): 161-171; 187-235
Martins, E.; Cardoso, J.é S.; Campelo, M.; Amorim, S.; Moura, B.; Maciel, M.J.úl.; Gonçalves, F.R. 2009: Survival of patients with familial dilated cardiomyopathy on optimal heart failure therapy Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 28(3): 263-268
Samsonov, M.A.; Vasil'ev, A.V.; Pogozheva, A.V.; Pokrovskaia, G.R.; Mal'tsev, G.I.; Biiasheva, I.R.; Orlova, L.A. 1992: The effect of a soy protein isolate and sources of polyunsaturated omega-3 fatty acids in an anti-atherosclerotic diet on the lipid spectrum of blood serum and immunological indicators in patients with ischemic heart disease and hypertension Voprosy Meditsinskoi Khimii 38(5): 47-50
Manelis, G.; Shasha, S.; Churi, O.; Manelis, J.; Cohen, A. 1974: Prevalence of atherosclerotic heart disease among the Druze of Western Galilee Harefuah 86(10): 493-496
Zhong, Y.-g.; Wang, N.-f.; Li, H.; Guo, S.-z.; Zhou, Z.-l.; Tong, G.-x.; Lin, J.; Sheng, G.-a.; Wang, Y.-b.; Xu, P.; Liu, Y.; Zou, J.-w. 2010: Management of coronary atherosclerotic heart disease through an alliance of community and hospital Zhonghua Yi Xue Za Zhi 90(38): 2675-2678
Maseri, A.; Chierchia, S.; L'Abbate, A. 1980: Pathogenetic mechanisms underlying the clinical events associated with atherosclerotic heart disease Circulation 62(6 Part 2): V3-V13
Stone, J.A.; Cyr, C.; Friesen, M.; Kennedy-Symonds, H.; Stene, R.; Smilovitch, M. 2001: Canadian guidelines for cardiac rehabilitation and atherosclerotic heart disease prevention: a summary Canadian Journal of Cardiology 17 Suppl B: 3b
Hammermeister, K.E. 1981: The effect of surgical therapy on covariate-survival relationships in patients with mitral valve disease Herz 6(4): 226-236
Zhdan, V.; Khaymenova, G.; Shilkina, L.; Martynyuk, D.; Babanina, M.; Mamontova, T. 2017: Determine the effectiveness of lipid-lowering therapy in patients with chronic obstructive pulmonary disease combined with coronary heart disease Wiadomosci Lekarskie 70(2 Part 2): 303-305
Perloff, J.K.; Lindgren, K.M. 1974: Adult survival in congenital heart disease. 3. Common and uncommon defects with exceptional adult survival Geriatrics 29(8): 93
Fabris, F.; Casonato, A.; Randi, M.L.; Schivazappa, L.; Schiavinato, L.; Girolami, A. 1983: Failure of sulphinpyrazone to affect platelet survival in patients with rheumatic heart valvular disease: a double blind study using 75Se-methionine labeled platelets Folia Haematologica 110(4): 594-601
Perloff, J.K.; Lindgren, K.M. 1974: Adult survival in congenital heart disease. 2. Uncommon defects with expected adult survival Geriatrics 29(6): 99